EU turns to BioNTech/Pfizer after J&J vaccine suspension

The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, its chief Ursula von der Leyen said Wednesday.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *